Our research

Our team brings together world leaders to improve child neurodevelopment and mental wellbeing.

We collaborate with communities, industry partners, government, community groups and treatment providers to apply our research in the real world, through policy and practice.

The ForeFront Ageing and Neurodegeneration team is committed to discovering early detection methods, identifying new treatments and understanding the underlying mechanisms of neurodegenerative disease.  

We are changing the way mental healthcare is delivered to young people impacted by mental ill-health. Rather than rely on broad diagnostic generalisations, we aim to support a mental health care model that enables young people to receive treatment that caters to their individual needs.

Focused on transforming neuroradiology services and translational neuroimaging research through innovations in artificial Intelligence (AI), imaging engineering, advanced imaging biomarkers and informatics and improving quality of care for degenerative neurological diseases.

Our sleep and circadian biology team focuses on improving our understanding of how changes to our sleep and body rhythms effect diseases of the brain. We're examining interventions for sleep-wake disturbances to improve brain health.

Our neuroimmunology team examines the link between dysregulations of the immune system and its impact on neurological disorders such as multiple sclerosis and dementia, as well as psychiatric diseases including schizophrenia.

The Lambert Initiative was created when Barry and Joy Lambert made a $33.7 million donation for research into the therapeutic use of medicinal cannabis.